1-196907017-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001201550.3(CFHR4):c.596C>A(p.Ser199Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000453 in 1,610,740 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S199F) has been classified as Uncertain significance.
Frequency
Consequence
NM_001201550.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFHR4 | NM_001201550.3 | c.596C>A | p.Ser199Tyr | missense_variant | 4/10 | ENST00000608469.6 | NP_001188479.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFHR4 | ENST00000608469.6 | c.596C>A | p.Ser199Tyr | missense_variant | 4/10 | 1 | NM_001201550.3 | ENSP00000477162.2 |
Frequencies
GnomAD3 genomes AF: 0.000205 AC: 31AN: 151196Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000486 AC: 12AN: 247060Hom.: 0 AF XY: 0.0000448 AC XY: 6AN XY: 133986
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1459428Hom.: 2 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 725884
GnomAD4 genome AF: 0.000211 AC: 32AN: 151312Hom.: 1 Cov.: 32 AF XY: 0.000189 AC XY: 14AN XY: 73934
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.596C>A (p.S199Y) alteration is located in exon 4 (coding exon 4) of the CFHR4 gene. This alteration results from a C to A substitution at nucleotide position 596, causing the serine (S) at amino acid position 199 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 26, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at